A recent study analyzed the association between metformin and the risk of developing non-melanoma skin cancers. The results indicate a reduced risk of squamous and basal cell carcinoma following exposure to metformin, with varying effects among demographic groups. The study proposed mechanisms through which metformin may exert protective effects and emphasized the need for further research, particularly in diverse populations.